Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Tech · Services-Computer Processing & Data Preparation

Vera Whole Health, Inc. to acquire Castlight Health, Inc.

Announced Jan 5, 2022 · Closed Feb 17, 2022

Deal value$370MEV $310M
Premium25.0%To unaffected price
EV / Adj. EBITDA—2.2x EV / Revenue
ConsiderationAll cash

Transaction

Acquirer
Vera Whole Health, Inc.
Target
Castlight Health, Inc.
Buyer type
Strategic
Offer price per share
—
Enterprise value
$310M
Status
Closed Feb 17, 2022

Deal protections

Break fee (target pays)
$13.4M · 3.6%
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
William Blair
William Blair fee
$3.1M

Sector context · Tech

Comparable deals
51 in the prior 24 months
Premium
25.0% vs. 30.8% sector median
EV / Adj. EBITDA
Sector median 17.4x
Break fee
3.6% vs. 3.0% sector median

Timeline

  1. AnnouncedJan 5, 2022
  2. Tender offerJan 19, 2022
  3. ClosedFeb 17, 2022

Valuation · fairness opinions

Discounted cash flow$1.33$2.13

Implied value per Castlight Health, Inc. share by analysis, from William Blair · DCF discount rate 10%–12%.

Sources
  • 8-K · Jan 5, 2022
  • 8-K (EX-99.1) · Feb 17, 2022

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.